Combined model with acoustic radiation force impulse to rule out high-risk varices in HBV-related cirrhosis with viral suppression

被引:4
作者
Wang, Haiyu [1 ]
Xi, Ranran [1 ]
Song, Jiankang [1 ]
Wen, Biao [1 ,2 ,3 ]
Zhang, Yuanjian [1 ]
Zhou, Ling [1 ]
Zhang, Xiaofeng [1 ,4 ]
Li, Yuan [1 ]
Zhou, Fuyuan [1 ]
Zhu, Youfu [1 ]
Ji, Yali [1 ]
Lai, Qintao [1 ]
He, Qinjun [1 ]
Luo, Wenfan [1 ]
Qi, Tingting [1 ]
Liu, Miaoxia [1 ]
Lan, Xiaoqin [1 ]
Dai, Lin [1 ,5 ]
Chen, Jinjun [1 ,4 ,5 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Hepatol Unit,Guangdong Prov Key Lab Viral Hepatiti, Guangzhou, Peoples R China
[2] First Affiliated Hosp, Chengdu Med Coll, Dept Gastroenterol, Chengdu, Peoples R China
[3] Chengdu Med Coll, Chengdu, Sichuan, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Hepatol, Zengcheng Branch, Guangzhou, Peoples R China
[5] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Hepatol Unit,Guangdong Prov Key Lab Viral Hepatiti, 1838 Guangzhou Dadao Bei, Guangzhou 510515, Peoples R China
基金
中国国家自然科学基金;
关键词
Liver cirrhosis; High-risk varices; Liver stiffness measurement; Spleen stiffness measurement; PORTAL-HYPERTENSION; SPLEEN STIFFNESS; LIVER; ERADICATION; UPDATE;
D O I
10.1016/j.dld.2023.02.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims: To prospectively evaluate the performance of spleen stiffness measurement (SSM) and liver stiffness measurement (LSM) via acoustic radiation force impulse (ARFI) imaging combined with platelet counts (PLT) in ruling out HRV in HBV-related cirrhotic patients with viral suppression. Methods: Patients with cirrhosis enrolled between June 2020-March 2022 were divided into a derivation cohort and validation cohort. LSM and SSM ARFI-based, and esophagogastroduodenoscopy (EGD) were performed at enrollment. Results: In the derivation cohort, overall, 236 HBV-related cirrhotic patients with maintained viral suppression were enrolled, and the prevalence of HRV was 19.5% (46/236). With the aim of identifying HRV, the most accurate LSM and SSM cut-offs were chosen of 1.46 m/s and 2.28 m/s, respectively. The combined model (LSM < 1.46 m/s and PLT > 150 x 10 9 /L strategy combined with SSM < 2.28 m/s) can spare 38.6% of EGDs and 4.3% of HRV cases were misclassified. In the validation cohort, we analysed 323 HBVrelated cirrhotic patients with maintained viral suppression and validated the combined model can spare 33.4% (108/323) of EGD, and the HRV missed rate was 3.4%. Conclusions: A non-invasive prediction model combining LSM < 1.46 m/s and PLT > 150 x 10 9 /L strategy with SSM < 2.28 m/s exhibited excellent performance in ruling out HRV and avoided a significantly large number (38.6% vs 33.4%) of unnecessary EGDs in HBV-related cirrhotic patients with viral suppression. & COPY; 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1062 / 1071
页数:10
相关论文
共 20 条
  • [1] Non-invasive evaluation of portal hypertension using ultrasound elastography
    Berzigotti, Annalisa
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 399 - 411
  • [2] Cho YS, 2020, ULTRASCHALL MED
  • [3] A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease
    Colecchia, Antonio
    Ravaioli, Federico
    Marasco, Giovanni
    Colli, Agostino
    Dajti, Elton
    Di Biase, Anna Rita
    Reggiani, Maria Letizia Bacchi
    Berzigotti, Annalisa
    Pinzani, Massimo
    Festi, Davide
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 308 - 317
  • [4] Baveno VII - Renewing consensus in portal hypertension
    de Franchis, Roberto
    Bosch, Jaime
    Garcia-Tsao, Guadalupe
    Reiberger, Thomas
    Ripoll, Cristina
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (04) : 959 - 974
  • [6] EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
    Dietrich, Christoph F.
    Bamber, Jeffrey
    Berzigotti, Annalisa
    Bota, Simona
    Cantisani, Vito
    Castera, Laurent
    Cosgrove, David
    Ferraioli, Giovanna
    Friedrich-Rust, Mireen
    Gilja, Odd Helge
    Goertz, Ruediger Stephan
    Karlas, Thomas
    de Knegt, Robert
    de Ledinghen, Victor
    Piscaglia, Fabio
    Procopet, Bogdan
    Saftoiu, Adrian
    Sidhu, Paul S.
    Sporea, Ioan
    Thiele, Maja
    [J]. ULTRASCHALL IN DER MEDIZIN, 2017, 38 (04): : E16 - E47
  • [7] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
    Angeli P.
    Bernardi M.
    Villanueva C.
    Francoz C.
    Mookerjee R.P.
    Trebicka J.
    Krag A.
    Laleman W.
    Gines P.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 406 - 460
  • [8] A strategy for varices screening based on acoustic radiation force impulse combined with platelet (CHESS2001): An alternative of Baveno VI criteria
    Huang, Yifei
    Zhao, Lili
    He, Ruiling
    Li, Shuang
    Liu, Chuan
    Qi, Xiaolong
    Li, Jia
    [J]. HEPATOLOGY COMMUNICATIONS, 2022, 6 (11) : 3154 - 3162
  • [9] Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices
    Kim, Hwi Young
    So, Young Ho
    Kim, Won
    Ahn, Dong-Won
    Jung, Yong Jin
    Woo, Hyunsik
    Kim, Donghee
    Kim, Moon Young
    Baik, Soon Koo
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 412 - 422
  • [10] Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
    Lens, Sabela
    Baiges, Anna
    Alvarado-Tapias, Edilmar
    LLop, Elba
    Martinez, Javier
    Ignacio Fortea, Jose
    Ibanez-Samaniego, Luis
    Marino, Zoe
    Rodriguez-Tajes, Sergio
    Gallego, Adolfo
    Banares, Rafael
    Puente, Angela
    Albillos, Agustin
    Luis Calleja, Jose
    Torras, Xavier
    Hernandez-Gea, Virginia
    Bosch, Jaume
    Villanueva, Candid
    Carlos Garcia-Pagan, Juan
    Forns, Xavier
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1415 - 1424